CYTOSORBENTS CORPORATION
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $26.9M | $89.5M | $52.1M |
| FY2022 | $27.9M | $63.2M | $22.1M |
| FY2023 | $27.5M | $57.5M | $14.1M |
| FY2024 | $27.4M | $47.1M | $3.3M |
| FY2025 | $38.3M | $44.2M | $6.2M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $26.9M | $89.5M | $52.1M |
| FY2022 | $27.9M | $63.2M | $22.1M |
| FY2023 | $27.5M | $57.5M | $14.1M |
| FY2024 | $27.4M | $47.1M | $3.3M |
| FY2025 | $38.3M | $44.2M | $6.2M |